期刊文献+

上海地区汉族人群LMTK2与MSMB基因多态性与前列腺癌的易感性 被引量:2

LMTK2 and MSMB gene polymorphisms and genetic susceptibility to prostate cancer in the Han population in Shanghai
下载PDF
导出
摘要 目的:探讨中国上海地区汉族人群中LMTK2与MSMB基因多态性与前列腺癌遗传易感性的关系。方法:采用病例对照研究,提取200例前列腺癌患者(病例组)和200例非前列腺癌健康人(对照组)外周血中基因组DNA,应用ABI3730XL测序仪分析病例组和对照组的LMTK2基因rs6465657位点以及MSMB基因rs10993994位点的多态性,比较不同基因型与前列腺癌易感性的关系。结果:MSMB基因rs10993994位点密码子T/C基因型的个体其前列腺癌发病风险是C/C基因型的1.62倍(OR=1.62,95%可信区间:1.12~2.27),携带MSMB基因rs10993994位点等位基因T(T/T,T/C)的个体发生前列腺癌的风险性是C/C基因型的0.96倍(OR=0.96,95%可信区间:0.82~1.11)。LMTK2基因rs6465657位点密码子C/C基因型的个体其前列腺癌发病风险与T/C基因型无明显差异。结论:中国上海地区汉族人群中MSMB基因rs10993994位点多态性可能对前列腺癌遗传易感性有影响,而LMTK2基因rs6465657位点对前列腺癌遗传易感性无明显影响。 OBJECTIVE: To investigate the correlation between LMTK2, MSMB gene polymorphisms and genetic susceptibility to prostate cancer in the Han population in Shanghai. METHODS: A case control experiment was performed, consisting of 200 cases with newly diagnosed prostate cancer and 200 cancer-free healthy controls. Then peripheral blood genome DNA was extracted. ABI 3730 XL sequenator was used to determine the polymorphism of LMTK2 gene at rs6465657 site and MSMB gene at rs10993994 site. The correlation between the two gene and susceptibility to prostate cancer. RESULTS: MSMB gene at rs10993994 site genetype TIC had a large risk to get prostate cancer compared with genetype C/C (OR=1.62, 95% CI 1.12-2.27). MSMB gene at rs10993994 site allele T (T/T, T/C) had a large risk to get prostate cancer compared with genetype C/C (OR=0.96, 95% CI 0.82-1.11). LMTK2 gene at rs6465657 site did not have significant difference between C/C genetype and TIC genetype. CONCLUSION: MSMB gene at rs10993994 site polymorphism may influence the genetic susceptibility to prostate cancer in the Han population in Shanghai, while LMTK2 gene at rs6465657 site has no obvious effect.
出处 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2009年第41期8170-8173,共4页 Journal of Clinical Rehabilitative Tissue Engineering Research
  • 相关文献

参考文献3

  • 1王书奎,王自正,黄宇烽.单核苷酸多态性与前列腺癌关系的研究进展[J].中华男科学杂志,2005,11(8):605-610. 被引量:5
  • 2Michelle Guy,Zsofia Kote-Jarai,Graham G. Giles,Ali Amin Al Olama,Sarah K. Jugurnauth,Shani Mulholland,Daniel A. Leongamomlert,Stephen M. Edwards,Jonathan Morrison,Helen I. Field,Melissa C. Southey,Gianluca Severi,Jenny L. Donovan,Freddie C. Hamdy,David R Dearnaley,Kenneth R. Muir,Charmaine Smith,Melisa Bagnato,Audrey T. Ardern-Jones,Amanda L. Hall,Lynne T. O'Brien,Beatrice N. Gehr-Swain,Rosemary A. Wilkinson,Angela Cox,Sarah Lewis,Paul M. Brown,Sameer G. Jhavar,Malgorzata Tymrakiewicz,Artitaya Lophatananon,Sarah L. Bryant,The UK Genetic Prostate Cancer Study Collaborators,British Association of Urological Surgeons' Section of Oncology and The UK ProtecT Study Collaborators,Alan Horwich,Robert A. Huddart,Vincent S. Khoo,Christopher C. Parker,Christopher J. Woodhouse,Alan Thompson,Tim Christmas,Chris Ogden,Cyril Fisher,Charles Jameson,Colin S. Cooper,Dallas R. English,John L. Hopper,David E. Neal,Douglas E Easton,Rosalind A. Eeles.Identification of new genetic risk factors for prostate cancer[J].Asian Journal of Andrology,2009,11(1):49-55. 被引量:1
  • 3管同郁,李鸣,刘三震,李瑶,周利群,那彦群.CYP1A1与GSTM1基因多态性与前列腺癌易感性的关系[J].中华泌尿外科杂志,2004,25(10):697-700. 被引量:6

二级参考文献40

  • 1Hein DW, Left MA, Ishibe N, et al. Association of prostate cancer with rapid N-acetyltransferase 1 (NAT1 * 10) in combination with slow N-acetyltransferase 2 acetylator genotypes in a pilot case-control study [ J ]. Environ Mol Mutagen, 2002, 40 (3) :161-167.
  • 2Xu J, Zheng SL, Turner A, et al. Associations between hOGG1 sequence variants and prostate cancer susceptibility [ J ]. Cancer Res, 2002, 62(8) :2253-2257.
  • 3Chang BL, Zheng SL, Isaacs SD, et al. Polymorphisms in the CYP1A1 gene are associated with prostate cancer risk [ J]. Int J Cancer, 2003, 106(3) :375-378.
  • 4Suzuki K, Matsui H, Nakazato H, et al. Association of the genetic polymorphism in cytochrome P450 (CYP) 1 A1 with risk of familial prostate cancer in a Japanese population: a case-control study [J]. Cancer Lett, 2003, 195(2):177-183.
  • 5Ribeiro R, Vasconcelos A, Costa S, et al. Overexpressing leptin genetic polymorphism (-2548 G/A ) is associated with susceptibility to prostate cancer and risk of advanced disease [ J ]. Prostate, 2004, 59(3):268-274.
  • 6Zheng SL, Augustsson-Balter K, Chang B, et al. Sequence variants of toll-like receptor 4 are associated with prostate cancer risk :results from the CAncer Prostate in Sweden Study [ J ]. Cancer Res, 2004 , 64(8):2918-2922.
  • 7Paltoo D, Woodson K, Taylor P, et al. Prol2Ala polymorphism in the peroxisome proliferator-activated receptor-gamma (PPAR-gamma) gene and risk of prostate cancer among men in a large cancer prevention study [ J]. Cancer Lett, 2003, 191 ( 1 ) :67-74.
  • 8Chiang CH, Chen KK, Chang LS, et al. The impact of polymorphism on prostate specific antigen gene on the risk, tumor volume and pathological stage of prostate cancer [J]. J Urol, 2004, 171(4) :1529-1532.
  • 9Liu J, Zhang JS, Young CY, et al. Polymorphisms of prostatespecific antigen gene promoter: determination from cord blood collected on filter paper [J]. Ann Clin Lab Sci, 2003,33(4) :429-434.
  • 10Chang BL, Zheng SL, Isaacs SD, et al. A polymorphism in the CDKN1B gene is associated with increased risk of hereditary prostate cancer [J]. Cancer Res, 2004, 64(6) :1997-1999.

共引文献9

同被引文献23

  • 1Sei&nan H, Mushinski MH, Gelb SK, et al. Probabilities of eventually developing or dying of cancer: United States, 1985. CA Cancer J Clin, 1985, 35:36-56.
  • 2Silverberg E. Statistical and epidemiologic data on urologic cancer. Cancer, 1987, 60:692-717.
  • 3Hsing AW, Chokkalingam AP. Prostate cancer epidemiology. Front Biosci, 2006, 11 : 1388-1413.
  • 4Bao BY, Pao JB, Lin VC, et al. Individual and cumative association of prostate cancer susceptibility variants with clinicopathologic characteristics of the disease. Clin Chim Acta, 2010, 411:1232- 1237.
  • 5Liu F, Hsing AW, Wang X, et al. Systematic confirmation study of reported prostate cancer risk-associated single nucleotide polymorphisms in Chinese men. Cancer Sci, 2011, 102: 1916- 1920.
  • 6Zheng SL, Hsing AW, Sun J, et al. Association of 17 prostate cancer susceptibility loci with prostate cancer risk in Chinese men. Prostate, 2010, 70:425-432.
  • 7A10lama AA, Kote-Jarai Z, Giles GG, et al. Multiple loci on 8q24 associated with prostate cancer susceptibility. Nat Genet, 2009, 41 : 1058-1060.
  • 8Tefferi A, Levine RL, Lim KH, et al. Frequent TET2 mutations in systemic mastocytosis: clinical, KITD816V and FIP1L1- PDGFRA correlates. Leukemia, 2009, 23:900-904.
  • 9Abdel-Wahab O, Mullally A, Hedvat C, et al. Genetic characterization of TETI, TEq2, and TE/3 alterations in myeloid malignancies. Blood, 2009, 114:144-147.
  • 10Ko M, Huang Y, Jankowska AM, et al. Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2. Nature, 2010, 468:839-843.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部